Cargando…

LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma

Bladder cancer (BC) and Renal cell carcinoma(RCC) are the two most frequent genitourinary cancers in China. In this study, a comprehensive liquid chromatography—mass spectrometry (LC-MS) based method, which utilizes both plasma metabolomics and lipidomics platform, has been carried out to discrimina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiang, Zhang, Mingxin, Cheng, Xiangming, Liu, Xiaoyan, Sun, Haidan, Guo, Zhengguang, Li, Jing, Tang, Xiaoyue, Wang, Zhan, Sun, Wei, Zhang, Yushi, Ji, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243740/ https://www.ncbi.nlm.nih.gov/pubmed/32500026 http://dx.doi.org/10.3389/fonc.2020.00717

Ejemplares similares

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2019)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer
por: Yang, Ming, et al.
Publicado: (2023)

Characterization of LC-MS based urine metabolomics in healthy children and adults
por: Liu, Xiaoyan, et al.
Publicado: (2022)

A Comprehensive 2D-LC/MS/MS Profile of the Normal Human Urinary Metabolome
por: Xu, Jiyu, et al.
Publicado: (2022)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma Biomarker
por: Liu, Xiaoyan, et al.
Publicado: (2020)

LC–MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma
por: Liu, Xiaoyan, et al.
Publicado: (2022)

Targeted LC-MS/MS-based metabolomics and lipidomics on limited hematopoietic stem cell numbers
por: Schönberger, Katharina, et al.
Publicado: (2022)

Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS
por: Xu, Long, et al.
Publicado: (2021)

UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment
por: Wang, Zhan, et al.
Publicado: (2023)

Non-targeted metabolomics and lipidomics LC–MS data from maternal plasma of 180 healthy pregnant women
por: Luan, Hemi, et al.
Publicado: (2015)

Optimization of Mobile Phase Modifiers for Fast LC-MS-Based Untargeted Metabolomics and Lipidomics
por: Cajka, Tomas, et al.
Publicado: (2023)

Proteomic and Metabolomic Analyses of Right Ventricular Failure due to Pulmonary Arterial Hypertension
por: Qin, Xiaohan, et al.
Publicado: (2022)

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration
por: Zhao, Tantai, et al.
Publicado: (2023)

Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model
por: liu, Xiaoyan, et al.
Publicado: (2023)

LC-MS lipidomics of renal biopsies for the diagnosis of Fabry disease
por: Yazd, Hoda Safari, et al.
Publicado: (2021)

LC/MS-based untargeted lipidomics reveals lipid signatures of nonpuerperal mastitis
por: Chen, Xiaoxiao, et al.
Publicado: (2023)

Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS
por: Sun, Yuting, et al.
Publicado: (2021)

LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance
por: Wang, Yidan, et al.
Publicado: (2023)

Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Tian, Xiaoyi, et al.
Publicado: (2022)

Integrated LC-MS/MS system for plant metabolomics
por: Sawada, Yuji, et al.
Publicado: (2013)

Study on plasma metabolomics for HIV/AIDS patients treated by HAART based on LC/MS-MS
por: Lao, Donghui, et al.
Publicado: (2022)

Possibilities of Liquid Chromatography Mass Spectrometry (LC-MS)-Based Metabolomics and Lipidomics in the Authentication of Meat Products: A Mini Review
por: Harlina, Putri Widyanti, et al.
Publicado: (2022)

LC-MS and GC-MS based metabolomics platform for cancer research
por: Lu, Wenyun, et al.
Publicado: (2014)

Perturbations of Metabolomic Profiling of Spleen From Rats Infected With Clonorchis sinensis Determined by LC-MS/MS Method
por: Zhang, Xiaoli, et al.
Publicado: (2020)

Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses
por: Yu, Di, et al.
Publicado: (2020)

Serum Metabolomics and Ionomics Analysis of Hoof-Deformed Cows Based on LC-MS/MS and ICP-OES/MS
por: Deng, Chaoyang, et al.
Publicado: (2023)

An R package to analyse LC/MS metabolomic data: MAIT (Metabolite Automatic Identification Toolkit)
por: Fernández-Albert, Francesc, et al.
Publicado: (2014)

Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC–MS/MS and iTRAQ quantification
por: Guo, Zhengguang, et al.
Publicado: (2015)

Organization of GC/MS and LC/MS metabolomics data into chemical libraries
por: DeHaven, Corey D, et al.
Publicado: (2010)

Mass spectrometry dataset of LC-MS lipidomics analysis of Xenopus laevis optic nerve
por: Neag, Emily, et al.
Publicado: (2023)

LC–MS-based lipidomic analysis of liver tissue sample from spontaneously hypertensive rats treated with extract hawthorn fruits
por: Sun, Luping, et al.
Publicado: (2022)

Metabolomic and Lipidomic Analysis of Serum from Mice Exposed to an Internal Emitter, Cesium-137, Using a Shotgun LC–MS(E) Approach
por: Goudarzi, Maryam, et al.
Publicado: (2014)

LC-MS-based Metabolomics of Xenobiotic-induced Toxicities
por: Chen, Chi, et al.
Publicado: (2013)

Isotopic labeling-assisted metabolomics using LC–MS
por: Bueschl, C., et al.
Publicado: (2012)

Filtering procedures for untargeted LC-MS metabolomics data
por: Schiffman, Courtney, et al.
Publicado: (2019)

Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
por: Lindahl, Anna, et al.
Publicado: (2017)

Metabolomics meets functional assays: coupling LC–MS and microfluidic cell-based receptor-ligand analyses
por: Henquet, M. G. L., et al.
Publicado: (2016)

Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach
por: Su, Longxiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ilnfuler5mm069a2us8u4dug9s